- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
- You can view the full Pfizer Ratings Report.
There are too many companies in just about every sector of this market, Cramer says.
While the public seized on Mylan's price increases for EpiPens, the story of a common drug industry practice - increasing prices ahead of generics entering the market - got lost.
Pretty much every company you can think of has donated to the Clinton Foundation. So has Donald Trump. Should it matter?